Data Sheet 1_Korean Artemisia species: phylogenomic authentication, ethnopharmacology, and commercial applications.pdf

However, taxonomic ambiguity, chemical variability, and limited clinical validation constrain their reliable therapeutic and commercial utilization. This review critically examines how phylogenomic evidence can be integrated with ethnopharmacology and phytochemistry to strengthen the authentication, scientific evaluation, and quality-controlled development of Artemisia taxa occurring in Korea.

Its distinctive contribution is a Korea-focused synthesis linking chloroplast-genome variation, traditional medicinal categories, species-associated phytochemical profiles, pharmacological evidence, and commercial quality requirements. Complete plastome analyses provide greater phylogenetic resolution than many single-locus approaches, whereas variable regions such as ycf1, accD, and selected intergenic spacers offer candidate markers for species authentication.